Marta Seco-Cervera

Profesor ayudante doctor

Universitat Politècnica de València

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Marta Seco-Cervera is a Profesor ayudante doctor at Universitat de València, Spain. Her research focuses on gastrointestinal diseases, specifically the interplay between the immune system and metabolic pathways in conditions like inflammatory bowel disease and sarcopenia. Recent studies include investigating the role of macrophages in intestinal fibrosis and the influence of oxidative stress and miRNAs in autoimmune diseases.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

SPAIN

View details

Sara Calatayud

Full Professor

Universidad Católica de Valencia Facultad de Medicina

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marta Seco-Cervera

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

A disturbed metabolite-GPCR axis is associated with microbial dysbiosis in IBD patients: Potential role of GPR109A in macrophages

Resistance to apoptosis in complicated Crohn's disease: Relevance in ileal fibrosis

Circulating miR-28-5p is overexpressed in patients with sarcopenia despite long-term remission of Cushing's syndrome: a pilot study.

P2X7 Receptor Regulates Collagen Expression in Human Intestinal Fibroblasts: Relevance in Intestinal Fibrosis

Oxidative Stress and Epigenetics: miRNA Involvement in Rare Autoimmune Diseases

IFNγ-Treated Macrophages Induce EMT through the WNT Pathway: Relevance in Crohn’s Disease

SUCNR1 Mediates the Priming Step of the Inflammasome in Intestinal Epithelial Cells: Relevance in Ulcerative Colitis

Is the Macrophage Phenotype Determinant for Fibrosis Development?

Is the Macrophage Phenotype Determinant for Fibrosis Development?

Thioredoxin and Glutaredoxin Systems as Potential Targets for the Development of New Treatments in Friedreich’s Ataxia

Collaborators (8)

maria dolores ortiz-masia

Jesus Cosin roger

Carlos Romá-Mateo

Angeles Alvarez

Maria Dolores Barrachina

Federico Pallardó

José Luis García-Giménez

Sara Calatayud

Make your next move.